velocebio.com
VeloceBio - Custom and Collaborative Multiplex Protein Biomarker Assay Development and Design - Our Clients
http://www.velocebio.com/clients.php
We actively collaborate with many research groups on the Harvard Medical School campus. These include in part:. Dr Andrew Lichtman, BWH and HMS – mouse models of T cell mediated inflammation. Dr Charles Serhan, BWH and HMS – inflammation research in mice and man. Dr Gerry Pier, BWH, Channing Lab – vaccine and infectious disease projects. Dr Pedram Hamrah, MGH – eye inflammation and infections. Dr Rachel Clark, BWH and HMS – human T cell biology in the skin. VeloceBio LLC Website 2013.
joshuajohnsondesign.com
Portfolio – Joshua Johnson Design
http://www.joshuajohnsondesign.com/portfolio
Creative Graphic and Website Design Syracuse, NY. Branding & Identity. Branding & Identity. Welcome to my graphic and web design portfolio. If you like what you see, please contact me. To discuss your next project. Below is a small sampling of my work. As you will see, my styles vary greatly depending on the needs and desires of each individual customer. With over 20 years of professional experience, I am your one-stop solution for all your design, print, web development and multimedia needs.
ceo-roundtable.com
::- CEO Roundtable -::
http://www.ceo-roundtable.com/websites1.asp
Follow us on Twitter. Join us on LinkedIn. Loren G. Carlson Bio. Who Joins CEO Roundtable. Members in the News. Links to Members' Websites. The peers in my CEO Roundtable group are my trusted advisors. CEO, Ascent Therapeutics. I have been a member of the CEO Roundtable for seven years. During that time I have met . CEO, Odyssey Bay Ventures, Inc. Sign up to receive CEO Roundtable. Steven G. Cecil. 160; Company Name. 160; Website Address. Atlantic Consultants, Inc. Boston Neurofeedback Ctr., PC.
cambridgebiomed.com
clinical trials Archives - Cambridge Biomedical
http://www.cambridgebiomed.com/tag/clinical-trials
YOUR BIOANALYTICAL ASSAY CRO AND CLINICAL DIAGNOSTICS SOURCE. Contact Cambridge Biomedical for all your Flow Assay Needs. Click here to check out the Cambridge Biomedical Summer 2016 newsletter. The Importance of Sample Processing for Clinical Trials. We identified this issue several years ago and introduced a video service for our clients. These videos are specifically tailored to the study requirements and detail the complete process,from venipuncture through to sample shipment. If you would like to le...
cambridgebiomed.com
CRISPR Archives - Cambridge Biomedical
http://www.cambridgebiomed.com/tag/crispr
YOUR BIOANALYTICAL ASSAY CRO AND CLINICAL DIAGNOSTICS SOURCE. NIH panel to review proposal for first in human test of CRISPR. A federal advisory panel will review a proposal for the first in human test of CRISPR/cas9 gene-editing technology, according to the National Institutes of Health. Researchers at the University of Pennsylvania plan to edit two genes in T-cells using CRISPR in a study aimed at targeting myeloma, melanoma, and sarcoma tumor cells, reports MIT Technology Review. Read at BioPharma Dive.
cambridgebiomed.com
BIO 2015 Archives - Cambridge Biomedical
http://www.cambridgebiomed.com/tag/bio-2015
YOUR BIOANALYTICAL ASSAY CRO AND CLINICAL DIAGNOSTICS SOURCE. Cambridge Biomedical will be exhibiting at BIO 2015 in Philadelphia next week. Drop by and see us! Cambridge Biomedical will be at BIO 2015-Philadelphia June 15-18. Drop by and see us! Visit us on Assay Depot. Visit our FaceBook page. Visit our FaceBook page. Genetic Studies’ Lack of Diversity May Lead to Misdiagnoses, Researchers Say. DNA revelations from Ötzi the Iceman’s leather and furs. Zika found to remain in sperm for record six months.
cambridgebiomed.com
Cystic fibrosis drug offers hope to patients - Cambridge Biomedical
http://www.cambridgebiomed.com/2015/05/18/cystic-fibrosis-drug-offers-hope-to-patients
YOUR BIOANALYTICAL ASSAY CRO AND CLINICAL DIAGNOSTICS SOURCE. How DNA sequencing is transforming the hunt for new drugs. Targeting Antibiotic-Resistant Bacteria with CRISPR and Phages →. Cystic fibrosis drug offers hope to patients. A “groundbreaking” cystic fibrosis therapy could profoundly improve patients’ quality of life, say doctors. Patients often die before their 40s as mucus clogs and damages their lungs and leaves them prone to infection. One in every 2,500 babies in the UK has cystic fibrosis.
cambridgebiomed.com
Targeting Antibiotic-Resistant Bacteria with CRISPR and Phages - Cambridge Biomedical
http://www.cambridgebiomed.com/2015/05/19/targeting-antibiotic-resistant-bacteria-with-crispr-and-phages
YOUR BIOANALYTICAL ASSAY CRO AND CLINICAL DIAGNOSTICS SOURCE. Cystic fibrosis drug offers hope to patients. Cambridge Biomedical will be at BIO 2015-Philadelphia June 15-18 →. Targeting Antibiotic-Resistant Bacteria with CRISPR and Phages. Researchers develop a CRISPR-based, two-phage system that sensitizes resistant bacteria to antibiotics and selectively kills any remaining drug-resistant bugs. To deliver a specific CRISPR/Cas. The approach, developed by Udi Qimron. Leave a Reply Cancel reply. Cystic f...
tacitbio.com
Cambridge Biomedical, Inc. - TacitBio
http://www.tacitbio.com/cambridge-biomedical-inc/4587232340
Cambridge Biomedical, Inc. - TacitBio. Applying tacit knowledge to address the unmet needs in life sciences. Since becoming established in 1997, Cambridge Biomedical has supported sponsors and CRO’s developing customized assays for small and large molecules, biomarkers, diagnostics, and medical devices. The team has expertise and extensive experience in technology transfer, assay development, optimization and validation. Tacit Bio Innovation represents Cambridge Biomedical in Europe. To view the full ver...
SOCIAL ENGAGEMENT